These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24331839)

  • 1. Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
    Terra SB; Aubry MC; Yi ES; Boland JM
    Hum Pathol; 2014 Feb; 45(2):294-302. PubMed ID: 24331839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
    Liu L; Cohen C; Siddiqui MT
    Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
    El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
    Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
    Stoll LM; Johnson MW; Gabrielson E; Askin F; Clark DP; Li QK
    Cancer Cytopathol; 2010 Dec; 118(6):441-9. PubMed ID: 20830690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
    Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.
    Fatima N; Cohen C; Lawson D; Siddiqui MT
    Cancer Cytopathol; 2011 Apr; 119(2):127-33. PubMed ID: 21287692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
    Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T
    Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
    Kim MY; Go H; Koh J; Lee K; Min HS; Kim MA; Jeon YK; Lee HS; Moon KC; Park SY; Kim WH; Chung DH
    Histopathology; 2014 Aug; 65(2):195-206. PubMed ID: 24479710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
    An J; Park S; Sung SH; Cho MS; Kim SC
    Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
    El Hag M; Schmidt L; Roh M; Michael CW
    Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.
    Weissferdt A; Kalhor N; Rodriguez Canales J; Fujimoto J; Wistuba II; Moran CA
    Hum Pathol; 2017 Jan; 59():1-9. PubMed ID: 27569293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
    Ramos-Vara JA; Frank CB; DuSold D; Miller MA
    J Comp Pathol; 2016 Nov; 155(4):286-298. PubMed ID: 27567273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
    Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M
    Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
    Zhang C; Schmidt LA; Hatanaka K; Thomas D; Lagstein A; Myers JL
    Am J Clin Pathol; 2014 Sep; 142(3):320-4. PubMed ID: 25125621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.